Table 2.
Variable | ID4 Methylation | |||
na | Positive | Negative | P-valued | |
Total | 170 | 117 | 53 | |
Clinicopathological parameters: | ||||
Age at diagnosis | ||||
<50 years | 51 | 34 | 17 | 0.821 |
≥ 50 years | 111 | 76 | 35 | |
Tumour sizeb | ||||
pT1 | 62 | 24 | 44 | 0.247 |
pT2-4 | 91 | 27 | 7 | |
Lymph node statusb | ||||
pN0 | 74 | 43 | 31 | 0.030 |
pN1-3 | 62 | 47 | 15 | |
Histological grade | ||||
G1 | 14 | 10 | 4 | 0.944 |
G2 | 79 | 52 | 27 | |
G3 | 61 | 42 | 19 | |
Histological type | ||||
invasive ductal | 129 | 87 | 42 | 0.940 |
invasive lobular | 18 | 12 | 6 | |
other | 12 | 8 | 4 | |
Oestrogen receptor status | ||||
negative (IRSc 0–2) | 52 | 35 | 17 | 0.900 |
positive (IRS 3–12) | 101 | 69 | 32 | |
Progesterone receptor status | ||||
negative (IRS 0–2) | 57 | 39 | 18 | 0.920 |
positive (IRS 3–12) | 96 | 65 | 31 | |
ID4 mRNA expression x-fold | ||||
FC<2 | 8 | 0 | 8 | <0.001 |
FC≥2 | 38 | 31 | 7 |
a Only female patients with primary, unilateral, invasive breast cancer were included. Significant P- values are marked in bold face. bAccording to TNM classification by Sobin and Wittekind [37]. c IRS = Immuno-reactive score according to Remmele and Stegner [38]. dFisher's exact test. Significant P- values are marked in bold face.